January 2016 - Volume 30 - Issue 2 - Contributor Index

Alphabetical Search
Q
X
Author:

Treatment intensification followed by interleukin-7 reactivates HIV without reducing total HIV DNA: a randomized trial

Katlama, Christine; Lambert-Niclot, Sidonie; Assoumou, Lambert; More

AIDS. 30(2):221-230, January 2016.

Rilpivirine vs. efavirenz-based single-tablet regimens in treatment-naive adults: week 96 efficacy and safety from a randomized phase 3b study

van Lunzen, Jan; Antinori, Andrea; Cohen, Calvin J.; More

AIDS. 30(2):251-259, January 2016.

Rilpivirine vs. efavirenz-based single-tablet regimens in treatment-naive adults: week 96 efficacy and safety from a randomized phase 3b study

van Lunzen, Jan; Antinori, Andrea; Cohen, Calvin J.; More

AIDS. 30(2):251-259, January 2016.

Treatment intensification followed by interleukin-7 reactivates HIV without reducing total HIV DNA: a randomized trial

Katlama, Christine; Lambert-Niclot, Sidonie; Assoumou, Lambert; More

AIDS. 30(2):221-230, January 2016.

Residual immune activation in combined antiretroviral therapy-treated patients with maximally suppressed viremia

Guihot, Amélie; Dentone, Chiara; Assoumou, Lambert; More

AIDS. 30(2):327-330, January 2016.

Treatment intensification followed by interleukin-7 reactivates HIV without reducing total HIV DNA: a randomized trial

Katlama, Christine; Lambert-Niclot, Sidonie; Assoumou, Lambert; More

AIDS. 30(2):221-230, January 2016.

Residual immune activation in combined antiretroviral therapy-treated patients with maximally suppressed viremia

Guihot, Amélie; Dentone, Chiara; Assoumou, Lambert; More

AIDS. 30(2):327-330, January 2016.

Author:
Ball, Colin
Author:
Bañón, Sara
Author:
Bloch, Mark

Rilpivirine vs. efavirenz-based single-tablet regimens in treatment-naive adults: week 96 efficacy and safety from a randomized phase 3b study

van Lunzen, Jan; Antinori, Andrea; Cohen, Calvin J.; More

AIDS. 30(2):251-259, January 2016.

Author:
Boffito, Marta
Author:
Bosse, Matthew

Rilpivirine vs. efavirenz-based single-tablet regimens in treatment-naive adults: week 96 efficacy and safety from a randomized phase 3b study

van Lunzen, Jan; Antinori, Andrea; Cohen, Calvin J.; More

AIDS. 30(2):251-259, January 2016.

Author:
Brinkman, Kees
Author:
Bvumbwe, Alice

White matter structure alterations in HIV-1-infected men with sustained suppression of viraemia on treatment

Su, Tanja; Caan, Matthan W.A.; Wit, Ferdinand W.N.M.; More

AIDS. 30(2):311-322, January 2016.

Author:
Calin, Ruxandra

Residual immune activation in combined antiretroviral therapy-treated patients with maximally suppressed viremia

Guihot, Amélie; Dentone, Chiara; Assoumou, Lambert; More

AIDS. 30(2):327-330, January 2016.

Author:
Calvez, Vincent

Treatment intensification followed by interleukin-7 reactivates HIV without reducing total HIV DNA: a randomized trial

Katlama, Christine; Lambert-Niclot, Sidonie; Assoumou, Lambert; More

AIDS. 30(2):221-230, January 2016.

Residual immune activation in combined antiretroviral therapy-treated patients with maximally suppressed viremia

Guihot, Amélie; Dentone, Chiara; Assoumou, Lambert; More

AIDS. 30(2):327-330, January 2016.

Residual immune activation in combined antiretroviral therapy-treated patients with maximally suppressed viremia

Guihot, Amélie; Dentone, Chiara; Assoumou, Lambert; More

AIDS. 30(2):327-330, January 2016.

Author:
Chuck, Susan K.

Rilpivirine vs. efavirenz-based single-tablet regimens in treatment-naive adults: week 96 efficacy and safety from a randomized phase 3b study

van Lunzen, Jan; Antinori, Andrea; Cohen, Calvin J.; More

AIDS. 30(2):251-259, January 2016.

Treatment intensification followed by interleukin-7 reactivates HIV without reducing total HIV DNA: a randomized trial

Katlama, Christine; Lambert-Niclot, Sidonie; Assoumou, Lambert; More

AIDS. 30(2):221-230, January 2016.

Rilpivirine vs. efavirenz-based single-tablet regimens in treatment-naive adults: week 96 efficacy and safety from a randomized phase 3b study

van Lunzen, Jan; Antinori, Andrea; Cohen, Calvin J.; More

AIDS. 30(2):251-259, January 2016.

Author:
Cole, James H.

White matter structure alterations in HIV-1-infected men with sustained suppression of viraemia on treatment

Su, Tanja; Caan, Matthan W.A.; Wit, Ferdinand W.N.M.; More

AIDS. 30(2):311-322, January 2016.

Treatment intensification followed by interleukin-7 reactivates HIV without reducing total HIV DNA: a randomized trial

Katlama, Christine; Lambert-Niclot, Sidonie; Assoumou, Lambert; More

AIDS. 30(2):221-230, January 2016.

Residual immune activation in combined antiretroviral therapy-treated patients with maximally suppressed viremia

Guihot, Amélie; Dentone, Chiara; Assoumou, Lambert; More

AIDS. 30(2):327-330, January 2016.

Author:
Coutinho, Roel
Author:
Cromer, Deborah
Author:
Daar, Eric S.
Author:
Daly, Phil

Rilpivirine vs. efavirenz-based single-tablet regimens in treatment-naive adults: week 96 efficacy and safety from a randomized phase 3b study

van Lunzen, Jan; Antinori, Andrea; Cohen, Calvin J.; More

AIDS. 30(2):251-259, January 2016.

Author:
Dentone, Chiara

Residual immune activation in combined antiretroviral therapy-treated patients with maximally suppressed viremia

Guihot, Amélie; Dentone, Chiara; Assoumou, Lambert; More

AIDS. 30(2):327-330, January 2016.

Author:
Dorfman, David
Author:
Dubrow, Robert
Author:
Essex, Max

In-utero triple antiretroviral exposure associated with decreased growth among HIV-exposed uninfected infants in Botswana

Powis, Kathleen M.; Smeaton, Laura; Hughes, Michael D.; More

AIDS. 30(2):211-220, January 2016.

Author:
Falutz, Julian

HIV infection is independently associated with frailty in middle-aged HIV type 1-infected individuals compared with similar but uninfected controls

Kooij, Katherine W.; Wit, Ferdinand W.N.M.; Schouten, Judith; More

AIDS. 30(2):241-250, January 2016.

Author:
Fawzi, Wafaie

In-utero triple antiretroviral exposure associated with decreased growth among HIV-exposed uninfected infants in Botswana

Powis, Kathleen M.; Smeaton, Laura; Hughes, Michael D.; More

AIDS. 30(2):211-220, January 2016.

Author:
Garmon, Donald
Author:
Garner, Will

Rilpivirine vs. efavirenz-based single-tablet regimens in treatment-naive adults: week 96 efficacy and safety from a randomized phase 3b study

van Lunzen, Jan; Antinori, Andrea; Cohen, Calvin J.; More

AIDS. 30(2):251-259, January 2016.

White matter structure alterations in HIV-1-infected men with sustained suppression of viraemia on treatment

Su, Tanja; Caan, Matthan W.A.; Wit, Ferdinand W.N.M.; More

AIDS. 30(2):311-322, January 2016.

Author:
Gianella, Sara

HIV infection is independently associated with frailty in middle-aged HIV type 1-infected individuals compared with similar but uninfected controls

Kooij, Katherine W.; Wit, Ferdinand W.N.M.; Schouten, Judith; More

AIDS. 30(2):241-250, January 2016.

Author:
Gordon, Lori A.
Author:
Gross, Chloe
Author:
Guihot, Amélie

Residual immune activation in combined antiretroviral therapy-treated patients with maximally suppressed viremia

Guihot, Amélie; Dentone, Chiara; Assoumou, Lambert; More

AIDS. 30(2):327-330, January 2016.

Author:
Guzman, Paula

In-utero triple antiretroviral exposure associated with decreased growth among HIV-exposed uninfected infants in Botswana

Powis, Kathleen M.; Smeaton, Laura; Hughes, Michael D.; More

AIDS. 30(2):211-220, January 2016.

Author:
Jao, Jennifer

In-utero triple antiretroviral exposure associated with decreased growth among HIV-exposed uninfected infants in Botswana

Powis, Kathleen M.; Smeaton, Laura; Hughes, Michael D.; More

AIDS. 30(2):211-220, January 2016.

Author:
Jarosz, Jozef
Author:
Jere, Joyce M.

Treatment intensification followed by interleukin-7 reactivates HIV without reducing total HIV DNA: a randomized trial

Katlama, Christine; Lambert-Niclot, Sidonie; Assoumou, Lambert; More

AIDS. 30(2):221-230, January 2016.

Residual immune activation in combined antiretroviral therapy-treated patients with maximally suppressed viremia

Guihot, Amélie; Dentone, Chiara; Assoumou, Lambert; More

AIDS. 30(2):327-330, January 2016.

Author:
Khoo, Saye
Author:
Kohli, Anita

HIV infection is independently associated with frailty in middle-aged HIV type 1-infected individuals compared with similar but uninfected controls

Kooij, Katherine W.; Wit, Ferdinand W.N.M.; Schouten, Judith; More

AIDS. 30(2):241-250, January 2016.

Author:
Kottilil, Shyam
Author:
Kroon, Frank P.
Author:
La Mar, Melissa

Treatment intensification followed by interleukin-7 reactivates HIV without reducing total HIV DNA: a randomized trial

Katlama, Christine; Lambert-Niclot, Sidonie; Assoumou, Lambert; More

AIDS. 30(2):221-230, January 2016.

Treatment intensification followed by interleukin-7 reactivates HIV without reducing total HIV DNA: a randomized trial

Katlama, Christine; Lambert-Niclot, Sidonie; Assoumou, Lambert; More

AIDS. 30(2):221-230, January 2016.

Author:
Levy, Jay A.
Author:
Lisco, Andrea
Author:
Lockman, Shahin

In-utero triple antiretroviral exposure associated with decreased growth among HIV-exposed uninfected infants in Botswana

Powis, Kathleen M.; Smeaton, Laura; Hughes, Michael D.; More

AIDS. 30(2):211-220, January 2016.

White matter structure alterations in HIV-1-infected men with sustained suppression of viraemia on treatment

Su, Tanja; Caan, Matthan W.A.; Wit, Ferdinand W.N.M.; More

AIDS. 30(2):311-322, January 2016.

Author:
Mak, Johnson
Author:
Makhema, Joseph

In-utero triple antiretroviral exposure associated with decreased growth among HIV-exposed uninfected infants in Botswana

Powis, Kathleen M.; Smeaton, Laura; Hughes, Michael D.; More

AIDS. 30(2):211-220, January 2016.

Residual immune activation in combined antiretroviral therapy-treated patients with maximally suppressed viremia

Guihot, Amélie; Dentone, Chiara; Assoumou, Lambert; More

AIDS. 30(2):327-330, January 2016.